MET-Mediated Drug Resistance in Colorectal Cancer: In Silico Analysis of the Potential of Epicatechin-3-Gallate and Epigallocatechin-3-Gallate As Therapeutic Adjuvants. IHRJ 2026, 3 (1-Supp), 05-16. https://doi.org/10.47963/ihrj.v3i(1-Supp).2075.